Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 66Pancreatic Neoplasms 35Neuroblastoma 21Neoplasm Metastasis 21Neoplasms 16Colonic Neoplasms 15Stomach Neoplasms 14Rectal Neoplasms 13Esophageal Squamous Cell Carcinoma 9Sarcoma, Ewing 8Rhabdomyosarcoma 8Small Cell Lung Carcinoma 7Sarcoma 7Ovarian Neoplasms 6Lung Neoplasms 6Cholangiocarcinoma 6Esophageal Neoplasms 5Breast Neoplasms 5Adenocarcinoma Of Esophagus 5Medulloblastoma 4Endometrial Neoplasms 4Biliary Tract Neoplasms 4Adenocarcinoma 4Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Osteosarcoma 3Locally Advanced Rectal Cancer 3Glioma 3Glioblastoma 3Gastrointestinal Neoplasms 3

Interventions

Gemcitabine 3surufatinib 1nimotuzumab 1S 1 (combination) 1Oxaliplatin 1Mass Screening 1Leucovorin 1Irinotecan 1Hematologic Tests 1Fluorouracil 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic cancer, adult × Irinotecan × 1 year × Clear all
NCT03977233 2026-01-13

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
45 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡